XML 24 R13.htm IDEA: XBRL DOCUMENT v3.6.0.2
INTANGIBLE ASSETS
6 Months Ended
Jun. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS

NOTE 6: INTANGIBLE ASSETS

 

Intangible assets consisted of the following:

 

    June 30,     December 31,  
    2016     2015  
Patents   $ 1,630,000     $ 1,630,000  
Capitalized license costs     -       200,000  
Software     113,540       113,540  
Intangible assets     1,743,540       1,943,540  
Less: Accumulated amortization     (296,530 )     (242,975 )
Total intangible assets, net   $ 1,447,010     $ 1,700,565  

 

Intangible assets amounted to $1,743,540 and $1,943,540 as of June 30, 2016 and December 31, 2015, respectively, and consisted of patents, capitalized license costs and software acquired. The amortization period for the purchased software is 3 years. Amortization expense related to software for the three months ended June 30, 2016 and 2015 was $7,857 and $11,018, respectively and $15,713 and $22,829 for the six months ended June 30, 2016 and 2015, respectively.

 

Patents amounted to $1,630,000 as of June 30, 2016 and December 31, 2015, and mainly consisted of patents acquired from Acueity on September 30, 2012 in an asset purchase transaction. Patent assets are amortized based on their determined useful life, and tested annually for impairment. The amortization period was from 7 to 12 years. Amortization expense related to patents was $37,254 for the three months ended June 30, 2016 and 2015, respectively and $74,508 for the six months ended June 30, 2016 and 2015, respectively.

  

Capitalized license costs consist of fees paid to A5 Genetics KFT, Corporation, pursuant to which the Company received the world-wide (other than the European Union) exclusive license to use the software in the NextCYTE test. As the Company shifted its focus to developing pharmaceutical products and discontinued NextCYTE test development, the A5 agreement was terminated in February 2016 and the entire net assets of $163,333, including $36,666 in accumulated amortization was written off.

 

Future estimated amortization expenses as of June 30, 2016 for the five succeeding years is as follows:

  

For the Year Ending December 31,   Amounts  
2016 (includes the remainder of the year)   $ 87,600  
2017     169,576  
2018     149,623  
2019     149,015  
2020     149,015  
Thereafter     742,181  
    $ 1,447,010